References
- 1
Akiskal HS, Fuller MA, Hirschfeld RM, Keck Jr PE, Ketter TA, Weisler RH.
Reassessing carbamazepine in the treatment of bipolar patients: clinical implications
of new data.
CNS Spectr.
2005;
10
((6 Suppl 5))
1-13
- 2
Cavanagh J, Smyth R, Goodwin GM.
Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.
Acta Psychiatr Scand.
2004;
109
91-95
- 3
Jess GE, Smith DJ, MacKenzie C, Crawford C.
Carbamazepine and rebound mania.
Am J Psychiatry.
2004;
161
2132-2133
- 4
Macritichie KAN, Hunt NJ.
Does “rebound mania” occur after stopping carbamazepine? A pilot study.
J Psychopharmacol.
2000;
14
266-268
- 5
Mouaffak F, Gourevitch R, Baup N, Loo H, Olie JP.
Interrelations between lithium therapy, auto-immune thyroiditis and TSH. A case report.
Pharmacopsychiatry.
2006;
39
77-78
- 6
Scull D, Trimble MR.
Mania precipitated by carbamazepine withdrawal.
Br J Psychiatry.
1995;
167
698
Correspondence
C. Lange-Asschenfeldt
Department of Psychiatry and Psychotherapy
Division of Geriatric Psychiatry
Heinrich Heine University
Bergische Landstr. 2
40629 Düsseldorf
Phone: + 49/211/922 42 15
Fax: + 49/211/922 42 13
Email: christian.lange-asschenfeldt@lvr.de
